Pharmaceutical

Grey Wolf gains $50m boost for antigen modulation tech

Grey Wolf Therapeutics has concluded an oversubscribed $50m in Series B financing expansion to advance its antigen modulation technology.

May 25, 2024 - 04:00
Grey Wolf gains $50m boost for antigen modulation tech
Grey Wolf Therapeutics has concluded an oversubscribed $50m in Series B financing expansion to advance its antigen modulation technology.
Read the original article

Tags:

Previous Article

FDA advisory committee reviews Novo Nordisk insulin icodec for T1D

Next Article

Cystic fibrosis: global clinical trials landscape and treatments

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: LabCentral, a crucial Boston incubator for drug discovery, is slated to grow amid industry slowdown

STAT+: LabCentral, a crucial Boston incubator for drug ...

Jan 2, 2024

Why do some CAR-T cancer patients have severe complications? Data points to latent virus

Why do some CAR-T cancer patients have severe complicat...

Nov 9, 2023

A health system tests virtual reality to help train nurses

A health system tests virtual reality to help train nurses

Jul 26, 2023